Home valeant
 

Keywords :   


Tag: valeant

Valeant will buy eye surgery device maker Synergetics

2015-09-02 19:31:53| Biotech - Topix.net

Canadian drugmaker Valeant Pharmaceuticals said Wednesday it will buy eye surgery product maker Synergetics USA for as much as $192 million. Valeant has already announced two acquisitions worth at least $1 billion this year, so the purchase is relatively small by its standards.

Tags: buy eye device surgery

 

Valeant, AstraZeneca strike psoriasis deal

2015-09-01 13:41:52| Biotech - Topix.net

Canada's Valeant Pharmaceuticals International Inc. has struck a deal with AstraZeneca PLC for the rights to sell psoriasis treatment brodalumab after Amgen Inc. dropped its own collaboration with the U.K.-based drug maker over concerns about the drug's side effects. Valeant said on Tuesday that it will pay AstraZeneca $100 million upfront, with another $170 million in prelaunch milestones and up to $175 million following launch.

Tags: deal strike psoriasis astrazeneca

 
 

Valeant and NetApp are big market movers

2015-08-21 01:49:35| Chemicals - Topix.net

The drug developer will pay about $1 billion to buy Sprout Pharmaceuticals, which makes the first women's libido drug, Addyi. The maker of cellulose products used in a wide range of consumer goods is in a contract dispute with Eastman Chemical.

Tags: big market movers netapp

 

Valeant Profit Beats Estimates As U.S. Sales Stay Strong

2015-07-24 05:39:42| Biotech - Topix.net

Drugmaker Valeant Pharmaceuticals International Inc reported a better-than-expected quarterly profit, helped by strength in its dermatology business in the United States. The company also raised its earnings and revenue forecast for the year to reflect sales of recently acquired Salix Pharmaceuticals' irritable bowel syndrome drug, Xifaxan.

Tags: sales stay strong profit

 

Valeant Pharmaceuticals posts second-quarter loss, sales up from year ago

2015-07-23 15:18:16| Biotech - Topix.net

Valeant Pharmaceuticals International Inc. raised its financial outlook for the year as it reported a loss in its latest quarter. The drug company says it now expects revenue this year to total between $10.7 billion to $11.1 billion, up from its earlier guidance for between $10.4 billion and $10.6 billion.

Tags: year sales ago posts

 

Sites : [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] [15] [16] [17] [18] [19] [20] [21] [22] next »